We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > viral vectors

News List

Industry hustling to ensure supply of recombinant vector COVID-19 vaccines europeanpharmaceuticalreview
May 26, 2021
A new report suggests pharma is working hard to combat worldwide viral vectors shortage that could threaten the COVID-19 vaccine rollout.
Introducing ViroCell Biologics contractpharma
April 29, 2021
ViroCell Biologics, founded in the UK by a prolific academic viral vector manufacturing team, has officially launched. Viral vectors are the primary delivery method for innovative vaccines such as the Oxford/Astra Zeneca COVID vaccine, as well as ...
Orchard Therapeutics commits to gene therapies production facility with plans to hire 100 workers fiercepharma
December 14, 2018
Orchard Therapeutics said it intended to use some of the proceeds of an IPO to build a manufacturing facility for its gene therapies program and now it is.